Hi Bripoz,
Lets hope this presentation can clinch us a deal or lead to a crack at a phase 3 approval or bloody something.
We need some direction or we are always in the sights of the traders.
Nice claw back today but by rights we should be around the $1 2o mark imo.
Aloha.
Ann: Viralytics to Present New CAVATAK Clinical Data at AACR, page-7
-
- There are more pages in this discussion • 59 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)